Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
25981
Descripción
Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00428922
Link
https://clinicaltrials.gov/show/NCT00428922
Palabras clave
Versiones (2)
- 2/10/17 2/10/17 -
- 4/10/17 4/10/17 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
2 de octubre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Breast Cancer NCT00428922
Eligibility Breast Cancer NCT00428922
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00428922
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Breast Carcinoma | Neoplasm Metastasis
Item
histologically confirmed breast cancer with evidence of metastatic disease
boolean
C0678222 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
C0027627 (UMLS CUI [2])
HER2 Gene Expression High | HER2 FISH Positive
Item
her2 3+ or fish +
boolean
C0069515 (UMLS CUI [1,1])
C0017262 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,3])
C0069515 (UMLS CUI [2,1])
C0162789 (UMLS CUI [2,2])
C1446409 (UMLS CUI [2,3])
C0017262 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,3])
C0069515 (UMLS CUI [2,1])
C0162789 (UMLS CUI [2,2])
C1446409 (UMLS CUI [2,3])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Trastuzumab Absent | Exception Adjuvant therapy | Exception Neoadjuvant Therapy
Item
no prior trastuzumab, except as given in the adjuvant or neoadjuvant setting.
boolean
C0728747 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0677850 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0600558 (UMLS CUI [3,2])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0677850 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0600558 (UMLS CUI [3,2])
Chemotherapy Absent Neoplasm Metastasis
Item
no prior chemotherapy in the metastatic setting.
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
CNS metastases
Item
cns metastases
boolean
C0686377 (UMLS CUI [1])
Therapeutic radiology procedure
Item
prior radiation therapy within the last 4 weeks
boolean
C1522449 (UMLS CUI [1])
Pregnancy | Pregnancy test positive | Breast Feeding
Item
pregnant (positive pregnancy test) or lactating women
boolean
C0032961 (UMLS CUI [1])
C0240802 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0240802 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Major surgery | Incisional biopsy | Non healing wound | Traumatic injury | Major surgery Patient need for
Item
major surgical procedure, open biopsy, non-healing wounds, or significant traumatic injury within 28 days prior to starting study or anticipation of need for major surgical procedure during the study
boolean
C0679637 (UMLS CUI [1])
C0184922 (UMLS CUI [2])
C0750433 (UMLS CUI [3])
C3263723 (UMLS CUI [4])
C0679637 (UMLS CUI [5,1])
C0686904 (UMLS CUI [5,2])
C0184922 (UMLS CUI [2])
C0750433 (UMLS CUI [3])
C3263723 (UMLS CUI [4])
C0679637 (UMLS CUI [5,1])
C0686904 (UMLS CUI [5,2])
Minor Surgical Procedures | Fine needle aspiration | Core biopsy
Item
minor surgical procedures such as fine needle aspirations or core biopsies within 7 days prior to start of study.
boolean
C0038904 (UMLS CUI [1])
C1510483 (UMLS CUI [2])
C1318309 (UMLS CUI [3])
C1510483 (UMLS CUI [2])
C1318309 (UMLS CUI [3])